The management of intraductal papillary mucinous neoplasm (IPMN) continues to evolve. In
particular, the indications for resection of branch duct IPMN have changed from early …

The international consensus guidelines for management of intraductal papillary mucinous
neoplasm and mucinous cystic neoplasm of the pancreas established in 2006 have …

Pancreatic cysts are being identified with increasing frequency as a result of the escalating
use of crosssectional imaging, typically for unrelated reasons. 1, 2 The incidence of …

This book is the third volume of the 4th Edition of the WHO series on histological and genetic
typing of human tumours. It is an authoritative, concise reference book providing an …

Cystic lesions of the pancreas are increasingly recognized. While some lesions show
benign behaviour (serous cystic neoplasm), others have an unequivocal malignant potential …

Non-inflammatory cystic lesions of the pancreas are increasingly recognized. Two distinct
entities have been defined, ie, intraductal papillary mucinous neoplasm (IPMN) and …

Objective: To update the authors' experience with intraductal papillary mucinous neoplasms
(IPMNs) of the pancreas. Background Data: IPMNs are intraductal mucin-producing cystic …

Objective: To describe clinical characteristics and outcomes of a large cohort of intraductal
papillary mucinous neoplasms (IPMNs) of the pancreas affecting the main pancreatic duct …

Owing to improvements in imaging techniques, cystic lesions of the pancreas are being
identified more often, even in patients who are asymptomatic. These lesions range from …

Pancreatic cancer is still a dismal disease. The high mortality rate is mainly caused by the
lack of highly sensitive and specific diagnostic tools, and most of the patients are diagnosed …